2 FTSE 100 growth stocks you can retire on

These two defensive growth champions could be great investments for retirement.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Finding stocks that you can buy and hold the long term is a tricky process but there are some companies that are better suited to an extended holding period than others. Pension providers, for example, have a business model built around long-term investing and highly defensive medical as well as pharmaceutical companies are also well-positioned for the long term.

Long term growth 

Healthcare facilities operator Mediclinic International (LSE: MDC) has approximately 70 hospitals and over 40 clinics under its umbrella, and the company is well-positioned to profit from both the world’s ageing population and rising incomes in developing nations. 

The company’s hospitals are located in South Africa, Namibia, Switzerland, and the Middle East. Earnings growth has been explosive in recent years with revenue and pre-tax profit rising from $365m and $61.5m respectively in 2013 to an estimated $2.75bn and $296m for the fiscal year ending 31 March 2017. City analysts are expecting earnings per share to rise by nearly a third over the next three fiscal years. From a projected 29.8p for the fiscal year ending this March, earnings per share are expected to hit 41p for the year ending 31 March 2019.

Considering this growth as well as the company’s defensive nature, shares in Mediclinic look relatively attractively priced at current levels. 

Indeed, at the time of writing shares in the company trade at a forward (fiscal year ending 31 March 2018) P/E of 20.9, falling to 18.3 for the following year. For comparison, shares in peer NMC Health currently trade at a forward P/E of 28.2 and shares in Georgia Healthcare trade at a forward P/E of 25.4. On this basis, compared to its peer group, Mediclinic’s shares look undervalued and could be an attractive investment for both value and growth investors.

Explosive growth 

As the world’s population grows and ages, ConvaTec Group’s (LSE: CTEC) sales should only grow as the medical technology company expands to meet demand. 

It produces therapies for the management of chronic conditions, wound care and critical care. Even though shares in the company only began trading at the end of October, they have since risen by 42% as investors have brought into the company’s growth story. 

City analysts are expecting explosive growth in the years ahead. The company is projected to report a pre-tax profit of £316m for 2017, up from a pre-tax loss last year, and earnings per share are expected to grow by 54%. Next year earnings growth of 10% has been projected. If the company meets these forecasts, the shares are trading at a forward P/E of 21.6, which is slightly above that of peers such as Smith & Nephew plc. But if ConvaTec’s earnings continue to grow at a double-digit annual rate, the firm will soon grow into its valuation. 

What’s more, City analysts have forecast the dividend payout of 5.5p this year, giving a dividend yield of 1.7%. The payout is covered nearly three times by earnings per share, giving plenty of room for further payout growth or special dividends as expansion continues.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

Just released: November’s higher-risk, high-reward stock recommendation [PREMIUM PICKS]

Fire ideas will tend to be more adventurous and are designed for investors who can stomach a bit more volatility.

Read more »

Young female analyst working at her desk in the office
Investing Articles

Here’s how I’d target a £23k second income with £300 a month

If I was building a shares portfolio today, here's how I'd go about it. With these strategies I stand a…

Read more »

Investing Articles

Tesla stock, MicroStrategy: here’s what Hargreaves Lansdown investors bought last week

MicroStrategy and Tesla stock were among the most popular investments last week as Donald Trump boosted markets with his election…

Read more »

Investing Articles

1 AI stock worth considering now Stocks and Shares ISAs are safe!

The Budget brought good news for those of us with Stocks and Shares ISAs! I’ve been looking at this one…

Read more »

Engineer Project Manager Talks With Scientist working on Computer
Growth Shares

Up 41% in 1 year, I’m buying more of this growth trust for my Stocks and Shares ISA

A great performance over the last 12 months has pushed our writer to buy more of a very exciting investment…

Read more »

Investing Articles

3 reasons to like the Legal & General dividend

Christopher Ruane explains a trio of reasons why he likes the Legal & General dividend as a source of passive…

Read more »

Investing Articles

Down 16%+, here’s 2 unloved FTSE 100 shares for savvy investors to consider!

These FTSE 100 shares have slumped in the past six months. Royston Wild thinks long-term investors should pay them close…

Read more »

Girl buying groceries in the supermarket with her father.
Investing Articles

Down 15%, but the FTSE 100’s J Sainsbury has a dividend yield over 5%!

Is it time to consider shares in FTSE 100 supermarket chain J Sainsbury for a potentially enduring stream of chunky…

Read more »